Recursion Pharmaceuticals (RXRX) Stock Price
$4.83 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
3 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Recursion Pharmaceuticals, AI stock picks, stock alerts and much more.
RXRX AI Stock Analysis
Financial Performance
Recursion Pharmaceuticals' revenue has shown a positive trend, increasing by 226.9% from the previous quarter and by 2.3% year over year to $14.7M. However, the company is facing challenges in terms of profitability with a gross profit of -$7.1M and an operating income loss of -$191.4M, indicating significant operational expenses or cost inefficiencies that are affecting their bottom line negatively. The company's EBITDA ratio stands at -12.98 which is not encouraging.
Stock Price
The stock price has seen a downward trend with a decrease of -16.3% in the last month and -26.5% year-over-year currently trading at $4.83 well below its 200-day moving average of $6, suggesting bearish sentiment among investors for Recursion Pharmaceuticals' stock performance in the market place.The RSI value is nearly neutral at around 49 but it does not show any strong momentum either way.
Alternative Data Signals
In terms of alternative data signals, web traffic seems to be on decline with a decrease of -5.1%. Job postings have also decreased by -14%, possibly indicating slowed growth or restructuring within the company.A neutral business outlook reported by employees could indicate uncertainty about future prospects while substantial increase in social media followers could indicate growing brand awareness and public interest.
Conclusion
Taking into account financial performance indicators such as revenue trends and profitability ratios along with stock price movement and alternative data signals like web traffic trends, job postings and social media followers; Recursion Pharmaceuticals' stock appears to be underperforming currently due to negative profitability figures and downward trending stock prices despite increased revenues. The outlook based on alternative data signals is mixed with declining web traffic and job postings but growing social media presence.
Recursion Pharmaceuticals (RXRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Recursion Pharmaceuticals (RXRX), currently trading at $4.83, will... Sign up to access price prediction.
About RXRX
-
Recursion Pharmaceuticals, Inc.
-
Symbol
RXRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
RXRX Alternative Data
Web Traffic
Recursion Pharmaceuticals receives an estimated 68517 monthly visitors to recursion.com, which is down by -5.1% over the last month.
-
Web Traffic
68517
-
Change from Previous Month
5.1%
-
3 Month Change
46.8%
-
YoY Change
46.8%
Twitter Followers
Recursion Pharmaceuticals has 15,301 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.2% over the last month.
-
Twitter Followers
15301
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
5.5%
-
YoY Change
5.5%
Facebook Engagement
Recursion Pharmaceuticals has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
8.3%
-
1 Month Change
83.3%
-
3 Month Change
35.3%
-
YoY Change
35.3%
Youtube Subscribers
Recursion Pharmaceuticals has 18,900 subscribers on its main Youtube channel, up by 276.5% over the last month.
-
Youtube Subscribers
18900
-
Daily Change
3.3%
-
1 Month Change
276.5%
-
3 Month Change
388.4%
-
YoY Change
388.4%
Job Postings
Recursion Pharmaceuticals has an estimated 24 open job postings, which is down -7.7% over the last month.
-
Job Postings
24
-
Daily Change
25%
-
1 Month Change
7.7%
-
3 Month Change
14.3%
-
YoY Change
14.3%
Reddit Mentions
Recursion Pharmaceuticals has been mentioned an estimated 4 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
4
-
Daily Change
0%
-
1 Month Change
300%
-
3 Month Change
100%
Business Outlook
According to employee reviews, the business outlook among employees at Recursion Pharmaceuticals is 52 out of 100 (neutral), up by 4% over the last month.
-
Business Outlook
52
-
Change from Previous Month
4%
-
3 Month Change
30.7%
-
YoY Change
30.7%
News Mentions
Recursion Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Recursion Pharmaceuticals has 580 employees.
-
LinkedIn Employees
580
-
Daily Change
2%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
RXRX Financials
RXRX Key Metrics
-
Total Revenue
$14.7M
-
Net Income
-$202.5M
-
Earnings per Share
-$0.5
-
Free cash flow
-$133.8M
-
EBITDA
-$191.4M
-
EBITDA Ratio
-12.9785
-
Total Assets
$1.3B
RXRX 2-year Revenue & Income
RXRX 2-year Free Cash Flow
RXRX Technicals
RXRX SMA
RXRX RSI
FAQ
What's the current price of Recursion Pharmaceuticals (RXRX) Stock?
The price of an Recursion Pharmaceuticals (RXRX) share is $4.83.
What's the market cap of Recursion Pharmaceuticals?
The current market cap of Recursion Pharmaceuticals is 2.1B.
What are some stocks similar to Recursion Pharmaceuticals (RXRX) that investors often compare it to?
Recursion Pharmaceuticals (RXRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Recursion Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Recursion Pharmaceuticals' stock price to be around $4.9 in 2026. Starting from the current price of $4.83, this represents a 1.5% change in price, indicating a neutral outlook for the stock.
How to buy Recursion Pharmaceuticals (RXRX) Stock?
Recursion Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Recursion Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.